Protection of curcumin against amyloid-β-induced cell damage and death involves the prevention from NMDA receptor-mediated intracellular Ca²⁺ elevation

References

• Huang HC, Jiang ZF. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease. J Alzheimers Dis 2009;16:15–27
   PubMed Web of Science ®Google Scholar
• Muramori F, Kobayashi K, Nakamura I. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases. Psychiatry Clin Neurosci 1998;52:593–9
   PubMed Web of Science ®Google Scholar
• Blennow K, Bogdanovic N, Alafuzoff I, et al. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J Neural Transm 1996;103:603–18
   PubMed Web of Science ®Google Scholar
• Hynd MR, Scott HL, Dodd PR. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 2004;45:583–95
   PubMed Web of Science ®Google Scholar
• Ong WY, Tanaka K, Dawe GS, et al. Slow excitotoxicity in Alzheimer's disease. J Alzheimers Dis 2013;35:643–68
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Ono K, Yamada M. Review: curcumin and Alzheimer's disease. CNS Neurosci Ther 2010;16:285–97
   PubMed Web of Science ®Google Scholar
• Chandra V, Pandav R, Dodge HH, et al. Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology 2001;57:985–9
   PubMed Web of Science ®Google Scholar
• Wang Y, Yin H, Wang L, et al. Curcumin as a potential treatment for Alzheimer's disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am J Chin Med 2013;41:59–70
   PubMed Web of Science ®Google Scholar
• Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005;280:5892–901
   PubMed Web of Science ®Google Scholar
• Yanagisawa D, Taguchi H, Yamamoto A, et al. Curcuminoid binds to amyloid-beta1-42 oligomer and fibril. J Alzheimers Dis 2011;24:33–42
   PubMed Web of Science ®Google Scholar
• Yin HL, Wang YL, Li JF, et al. Effects of curcumin on hippocampal expression of NgR and axonal regeneration in Abeta-induced cognitive disorder rats. Genet Mol Res 2014;13:2039–47
   PubMed Web of Science ®Google Scholar
• Tiwari SK, Agarwal S, Seth B, et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/beta-catenin pathway. ACS Nano 2014;8:76–103
   PubMed Web of Science ®Google Scholar
• Huang HC, Chang P, Dai XL, Jiang ZF. Protective effects of curcumin on amyloid-beta-induced neuronal oxidative damage. Neurochem Res 2012;37:1584–97
   PubMed Web of Science ®Google Scholar
• Huang HC, Tang D, Xu K, Jiang ZF. Curcumin attenuates amyloid-beta-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3beta signaling pathway. J Recept Signal Transduct Res 2013;34:26–37
   PubMed Web of Science ®Google Scholar
• Wu QE, Zhen LX, Xie F, et al. Determination of the amino acids in rat brain by high-performance liquid chromatography and fluorescence detection. Fudan Univ J Med Sci 2005;32:355–8
   Google Scholar
• Rasmussen H, Isales C, Ganesan S, et al. Ca(2+)-cyclic AMP interactions in sustained cellular responses. Ciba Found Symp 1992;164:98–108; discussion 108–112
   PubMedGoogle Scholar
• Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256:184–5
   PubMed Web of Science ®Google Scholar
• Dong S, Duan Y, Hu Y, Zhao Z. Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis. Transl Neurodegener 2012;1:18
   PubMedGoogle Scholar
• Seino Y, Kawarabayashi T, Wakasaya Y, et al. Amyloid beta accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model. J Neurosci Res 2010;88:3547–54
   PubMed Web of Science ®Google Scholar
• Klein AM, Kowall NW, Ferrante RJ. Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1–40 in the mouse cerebral cortex. Ann N Y Acad Sci 1999;893:314–20
   PubMed Web of Science ®Google Scholar
• Bezprozvanny I, Mattson MP. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 2008;31:454–63
   PubMed Web of Science ®Google Scholar
• Brittain MK, Brustovetsky T, Sheets PL, et al. Delayed calcium dysregulation in neurons requires both the NMDA receptor and the reverse Na+/Ca2+ exchanger. Neurobiol Dis 2012;46:109–17
   PubMed Web of Science ®Google Scholar
• Solbu TT, Bjorkmo M, Berghuis P, et al. SAT1, a glutamine transporter, is preferentially expressed in GABAergic neurons. Front Neuroanat 2010;4:1
   PubMed Web of Science ®Google Scholar
• Buntup D, Skare O, Solbu TT, et al. Beta-amyloid 25-35 peptide reduces the expression of glutamine transporter SAT1 in cultured cortical neurons. Neurochem Res 2008;33:248–56
   PubMed Web of Science ®Google Scholar
• Revett TJ, Baker GB, Jhamandas J, Kar S. Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci 2013;38:6–23
   PubMed Web of Science ®Google Scholar
• Koh JY, Yang LL, Cotman CW. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990;533:315–20
   PubMed Web of Science ®Google Scholar
• Snyder EM, Nong Y, Almeida CG, et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 2005;8:1051–8
   PubMed Web of Science ®Google Scholar
• Danysz W, Parsons CG. Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine – searching for the connections. Br J Pharmacol 2012;167:324–52
   PubMed Web of Science ®Google Scholar
• McKay S, Bengtson CP, Bading H, et al. Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure. Neuropharmacology 2013;74:119–25
   PubMed Web of Science ®Google Scholar
• Fu Y, Zheng S, Lin J, et al. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 2008;73:399–409
   PubMed Web of Science ®Google Scholar
• Zhang C, Browne A, Child D, Tanzi RE. Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. J Biol Chem 2010;285:28472–80
   PubMed Web of Science ®Google Scholar